Diversifying Photochemical Reactivity of Diazo-oxochlorins
A R T I C L E S
Chinese hamster ovary and K562 cells,13 while in the broader
NCI 60-cell screen, kinamycin C reveals high nanomolar IC50
values similar to the potent antitumor agent mitomycin C. The
homodimer lomaiviticin A also exhibits activity against Gram-
positive bacteria and a variety of tumor cell lines, with IC50
values ranging from 0.7 to 6.0 nM.14 Despite these studies, and
the luxury of synthetic access to the kinamycin natural prod-
ucts,15 the precise mechanism of biological activity is still not
fully understood. However, it is generally accepted that the
reaction pathway responsible for cell growth inhibition involves
formation of a primary radical species via N2 loss.13,14 Along
with the enediyne natural products,16 the diazoparaquinone
antibiotics are a rare example of intramolecular diradical
generation via mild activation.
mediated PDT for hypoxic environments. Carbenes formed by
N2 loss can undergo alkylation reactions via the singlet
intermediates, or H-atom abstraction from external substrates
usually via the triplet state.42-44 Additionally, if the loss of
dinitrogen occurs from a R-diazo ketone framework, the
electron-deficient carbene can facilitate intramolecular Wolff
rearrangement,45,46 which results in a transient ketene that adds
nucleophiles.47,48 In this sense, biology provides a variety of
potential nucleophiles such as the sugar backbone of DNA and
other basic substrates.
With these motivations, we are pursuing the development and
diradical reactivity of diazo-oxochlorin chromophores.49-53 Due
to their intense absorption bands throughout the visible spectral
region,54,55 porphyrins and chlorins are routinely employed as
1
effective photosensitizers for O2 formation in PDT. Conse-
The uniqueness of N2 release as an entropically driven trigger
for reactivity leads to several potential biological applications
for diazo analogues that include nuclease activity,17-23 photo-
affinity labeling,24-38 and photodynamic therapy (PDT).39,40 The
quently, improved synthetic strategies have led to the develop-
ment of porphyrinoids with modulated optical56-59 and elec-
tronic properties.53,60-62 By combining the electronic features
of such chromophores with the alklyation, H-atom abstraction,
or Wolff reactivity of the diazo-moiety, novel porphyrin
photoreagents may be accessible.
41
formation of toxic radicals without the need for O2 suggests
that such compounds could be an alternative to traditional, 1O2-
Herein we describe the photoreactivity of diazo-oxochlorins
in the presence of nucleophilic substrates. Broadband photolysis
generates an initial carbene intermediate that differentiates
reactivity on the basis of the availability of nucleophile. In the
presence of substrates, the unique, ring-contracted azeteo-
porphyrin-substrate adducts are obtained, while in their ab-
sence, exocyclic ring formation and H-atom abstraction domi-
nate the product distribution. Photochemically initiated and
controlled addition chemistry of this type may ultimately find
utility in photobiological labeling and alkylation applications.
(14) Feldman, K. S.; Eastman, K. J. J. Am. Chem. Soc. 2005, 127, 15344.
(15) Lei, X.; Porco, J. A., Jr. J. Am. Chem. Soc. 2006, 128, 14790.
(16) Rawat, D. S.; Zaleski, J. M. Synlett 2004, 393.
(17) Behr, J. P. J. Chem. Soc., Chem. Commun. 1989, 101.
(18) Daidone, G.; Maggio, B.; Plescia, S.; Raffa, D.; Musiu, C.; Milia, C.;
Perra, G.; Marongiu, M. E. Eur. J. Med. Chem. 1998, 35, 375.
(19) Hiramoto, K.; Kaku, M.; Sueyoshi, A.; Fujise, M.; Kikugawa, K. Chem.
Res. Toxicol. 1995, 8, 356.
(20) Nakatani, K.; Maekawa, S.; Tanabe, K.; Saito, I. J. Am. Chem. Soc.
1995, 117, 10635.
(21) Nakatani, K.; Shirai, J.; Sando, S.; Saito, I. Tetrahedron Lett. 1997,
38, 6047.
(22) Nielsen, P. E.; Jeppesen, C.; Egholm, M.; Buchardt, O. Nucleic Acids
Res. 1988, 16, 3877.
Results
(23) Wu, F.; Bergstrom, M.; Stridsberg, M.; Orlefors, H.; Eriksson, B.;
Oberg, K.; Watanabe, Y.; Langstrom, B. Anticancer Res. 1997, 17,
2363.
Syntheses. The diazo-oxochlorins were prepared via published
methodology.51 Briefly, reaction of the corresponding metalated
dioxochlorin precursors and tosylhydrazine in the presence of
Zn(OAc)2 (1 equiv) in dichloromethane results in their genera-
tion in good yields (Ni1, 64%; Cu1, 73%). Demetalation with
(24) Blanton, M. P.; Dangott, L. J.; Raja, S. K.; Lala, A. K.; Cohen, J. B.
J. Biol. Chem. 1998, 273, 8659.
(25) DeGraw, A. J.; Zhao, Z.; Strickland, C. L.; Taban, A. H.; Hsieh, J.;
Jefferies, M.; Xie, W.; Shintani, D. K.; McMahan, C. M.; Cornish,
K.; Distefano, M. D. J. Org. Chem. 2007, 72, 4587–4595.
(26) Fagart, J.; Sobrio, F.; Marquet, A. J. Labelled Compds. Radiopharm.
1997, 39, 791.
(27) Fisher, A.; Mann, A.; Verma, V.; Thomas, N.; Mishra, R. K.; Johnson,
R. L. J. Med. Chem. 2006, 49, 307.
(42) Wentrup, C. ReactiVe Molecules; John Wiley and Sons: New York,
1984333.
(28) Fisher, A. L. Photoaffinity labeling and macrocyclic spiro bicyclic
analogs of the dopamine receptor modulator L-prolyl-L-leucyl-
glycinamide. Ph.D. Thesis, University of Minnesota, 2005.
(29) Gartner, C. A. Curr. Med. Chem. 2003, 10, 671.
(30) Hosoya, T.; Hiramatsu, T.; Ikemoto, T.; Aoyama, H.; Ohmae, T.; Endo,
M.; Suzuki, M. Bioorg. Med. Chem. Lett. 2005, 15, 1289.
(31) Hosoya, T.; Hiramatsu, T.; Ikemoto, T.; Nakanishi, M.; Aoyama, H.;
Hosoya, A.; Iwata, T.; Maruyama, K.; Endo, M.; Suzuki, M. Org.
Biomol. Chem. 2004, 2, 637.
(43) Bourissou, D.; Guerret, O.; Gabbaie, F. P.; Bertrand, G. Chem. ReV.
2000, 100, 39.
(44) Tomioka, H. Acc. Chem. Res. 1997, 30, 315.
(45) Bogdanova, A.; Popik, V. V. J. Am. Chem. Soc. 2004, 126, 11293.
(46) Urdabayev, N. K.; Popik, V. V. J. Am. Chem. Soc. 2004, 126, 4058.
(47) Ye, T.; McKervey, M. A. Chem. ReV. 1994, 94, 1091.
(48) Kirmse, W. Eur. J. Org. Chem. 2002, 2193.
(49) Cavaleiro, J. A. S.; Gerdan, V. M.; Hombrecher, H. K.; Neves,
M. G. P. M. S.; Silva, A. M. S. Heterocycl. Commun. 1997, 3, 253.
(50) Hombrecher, H. K.; Gerdan, V. M.; Cavaleiro, J. A. S.; Neves,
M. G. P. M. S. Heterocycl. Commun. 1997, 3, 453.
(51) Ko¨pke, T.; Pink, M.; Zaleski, J. M. Synlett 2006, 2183.
(52) Ko¨pke, T.; Pink, M.; Zaleski, J. M. Org. Biomol. Chem. 2006, 4, 4059.
(53) Ko¨pke, T.; Pink, M.; Zaleski, J. M. Chem. Commun. 2006, 4940.
(54) Holten, D.; Bocian, D. F.; Lindsey, J. S. Acc. Chem. Res. 2002, 35,
57.
(32) Kan, T.; Kita, Y.; Morohashi, Y.; Tominari, Y.; Hosoda, S.; Tomita,
T.; Natsugari, H.; Iwatsubo, T.; Fukuyama, T. Org. Lett. 2007, 9, 2055.
(33) Kim, E. Y. L.; Gronewold, C.; Chatterjee, A.; Von der Lieth, C.-W.;
Kliem, C.; Schmauser, B.; Wiessler, M.; Frei, E. ChemBioChem 2005,
6, 422.
(34) Knorre, D. G.; Godovikova, T. S. FEBS Lett. 1998, 433, 9.
(35) Lebedeva, N. A.; Rechkunova, N. I.; Khodyreva, S. N.; Favre, A.;
Lavrik, O. I. Biochem. Biophys. Res. Commun. 2002, 297, 714.
(36) Nagase, T.; Shinkai, S.; Hamachi, I. Chem. Commun. 2001, 229.
(37) Palmer, B. D.; Henare, K.; Woon, S.-T.; Sutherland, R.; Reddy, C.;
Wang, L.-C. S.; Kieda, C.; Ching, L.-M. J. Med. Chem. 2007, 50,
3757.
(55) Sessler, J. L.; Seidel, D. Angew. Chem., Int. Ed. 2003, 42, 5134.
(56) Nath, M.; Huffman, J. C.; Zaleski, J. M. J. Am. Chem. Soc. 2003,
125, 11484.
(57) Nath, M.; Pink, M.; Zaleski, J. M. J. Am. Chem. Soc. 2005, 127, 478.
(58) Aihara, H.; Jaquinod, L.; Nurco, D. J.; Smith, K. M. Angew. Chem.,
Int. Ed. 2001, 40, 3439.
(38) Pandurangi, R. S.; Lusiak, P.; Kuntz, R. R.; Volkert, W. A.; Rogowski,
J.; Platz, M. S. J. Org. Chem. 1998, 63, 9019.
(59) Shen, D.-M.; Liu, C.; Chen, Q.-Y. Chem. Commun. 2005, 4982.
(60) Crossley, M. J.; King, L. G. J. Chem. Soc., Chem. Commun. 1984,
920.
(39) Detty, M. R.; Gibson, S. L.; Wagner, S. J. J. Med. Chem. 2004, 47,
3897–3915.
(40) Jasat, A.; Dolphin, D. Chem. ReV. 1997, 97, 2267.
(41) Szacilowski, K.; Macyk, W.; Drzewiecka-Matuszek, A.; Brindell, M.;
Stochel, G. Chem. ReV. 2005, 105, 2647.
(61) Lara, K. K.; Rinaldo, C. R.; Bru¨ckner, C. Tetrahedron 2005, 61, 2529.
(62) Chandra, T.; Kraft, B. J.; Huffman, J. C.; Zaleski, J. M. Inorg. Chem.
2003, 42, 5158.
9
J. AM. CHEM. SOC. VOL. 130, NO. 47, 2008 15865